Company news
Electrocore, Inc. (NASDAQ:ECOR) news
Electrocore, Inc. news releases on 6ix. Latest, Sep 9, 2026: ElectroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers
Press releases & updates
ElectroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers
September 9, 2026
electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers
September 9, 2026
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards
August 25, 2026
ElectroCore Announces Second Quarter 2026 Financial Results
August 6, 2026
electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026
July 30, 2026
New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation
July 16, 2026
electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference
June 17, 2026
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
June 1, 2026
electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia
May 12, 2026
electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026
May 7, 2026
electroCore Announces First Quarter 2026 Financial Results
May 6, 2026
electroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge
April 30, 2026
electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026
April 29, 2026
electroCore to Present at the Market Movers Investor Summit on May 5, 2026
April 28, 2026
electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation
April 23, 2026
electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026
electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD
April 6, 2026
electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD
March 31, 2026
electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
March 30, 2026
ElectroCore Expands Intellectual Property Portfolio
March 30, 2026
electroCore Announces Full Year 2025 Financial Results and Organizational Changes
March 18, 2026
electroCore to Participate at the 38th Annual Roth Conference
March 10, 2026
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026
March 9, 2026
Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”)
January 21, 2026
electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million
January 20, 2026
TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen
December 2, 2025
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2025
electroCore Announces Third Quarter 2025 Financial Results
November 5, 2025
electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025
October 23, 2025
ElectroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(4)
October 6, 2025
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
October 3, 2025
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms
September 30, 2025
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
September 29, 2025
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
September 22, 2025
electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board
September 5, 2025
electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress Relief
September 4, 2025
electroCore Appoints Elena Bonfiglioli to Board of Directors
September 3, 2025
electroCore to Participate at H.C. Wainwright Global Investment Conference
September 2, 2025
electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga
August 12, 2025
electroCore Announces Second Quarter 2025 Financial Results
August 6, 2025
electroCore Appoints James C. Theofilos to the Board of Directors
August 5, 2025
electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025
July 23, 2025
electroCore to Participate in Upcoming Investor Conferences
July 22, 2025
electroCore Announces First Quarter 2025 Financial Results
May 7, 2025
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
May 2, 2025
electroCore’s Truvaga™ Now Works with the Apple Health app
May 1, 2025
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025
April 30, 2025
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries
April 17, 2025
electroCore to Participate at the Planet MicroCap Showcase
April 16, 2025
electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times
April 3, 2025